Stay updated on NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:28:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - Added Squamous cell carcinoma of the head and neck and Cutaneous neuroendocrine carcinoma to the study's conditions.
    Difference
    0.1%
    Check dated 2026-04-02T00:29:28.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-25T21:00:08.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:52:35.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; the previous notices about government funding lapse and operating status (Revision: v3.4.1) have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:50:12.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a government funding status notice informing users about potential processing delays and the NIH Clinical Center's status, and updated the site revision to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:53:55.000Z thumbnail image

Stay in the know with updates to NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.